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Conclusions: Over the time course of 3 months, the expansion index and
LVEDVI increased while liN ratio decreased in group II and not group I; thus in
this patient population, baseline left ventricular hypertrophy is an important
factor governing infarct expansion.
Antonio G. Rebuzzi, Gaetano Quaranta, Giovanna Liuzzo, Giuseppina Caligiuri.
Domenico Cianflone, Luigi M. Biasucci. Attilio Maseri. Cardiolog", Catholic
University, Rome. Italy
Troponin T (n), a specific marker of myocardial cell damage, and C reac-
tive protein (CAP). an acute phase reactant, were found to be prognostic of
outcome in unstable angina (UA) in different studies. We assessed the sen-
sitivity and specificity of these markers for myocardial infarction (MI), death
(D) and for the need of revascularization within a week after admission (A)
in a group of 90 pts with UA. Blood samples for n and CAP measurement
were taken on admission.
Results: 18/90 pts (20%) had elevated n levels on admission (mean 0.8,
range 0.2-4.3 1l9~, normal values <0.2 Ilg/l); 7 (39%) of these pts had MI
or D and 3 (17%) had A. 72/90 pts (80%) had normal n values; 8 (11%) of
these pts had Mlor D(p = 0.013) and 12 (17%) had R. Sensitivity of elevated
n values for MI or D was 67% and specificity 85%.
CAP was measured in 83 pts and was elevated (normal values < 3 mg/dl)
in 50 (62%).10 (20%) ofthese pts had MI or D and 11 (22%) had R. Only 2/33
pts (6%) with normal CAP levels had MI or D and 3/33 (9%) had A. Sensitivity
of CAP> 3 mgldl for MI or D was 83% and specificity 44%. 20/83 pts (24%)
had CAP values> 10 mg/dl; 8 (40%) of these pts had MI or D (p < 0.0007
versus pts with CAP < 10 mg/dl) and 8 pts (40%) required A(p = 0.004 versus
pts with CAP < 10 mg/dl). Sensitivity of CAP> 10 mg/dl for MI or D was 67%
and for A was 57%; specificity for MI or D and also for A was 83%.
The combination of elevated values of n and CAP was shown in 14/83
pts (17%); 6 (43%) of these pts had MI or D. while only 1/31 pts (3%) with
normal n and CAP had MI or D (p = 0.003). Sensitivity of elevated nand
CAP levels for MI or A was 43% and specificity 79%. Positive predictive value
was 43% and negative predictive value 97%.
These results indicate that n and CAP values on the admission are impor-
tant prognostic predictors of outcome in pts with UA, particularly when both
are elevated.
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Conclusions: 1) Although in the thrombolytic era the incidence of BBB at
presentation of acute MI may have decreased, this group of pts are at high
risk for 3D-day mortality; 2) Their poor prognosis does not seem to be re-
lated to a larger infarct size or more severe CHF. The role of septal asynergy,
late bradyarrhythmias, and electrical instability(perhaps related to autonomic
denervation of the conduction system) deserve further study; 3) Pts present-
ing with BBB during acute MI warrant especial surveillance and aggressive
management, which should probably include prophylactic pacing.
William R. Hathaway, K. Michael Zabel, Eric D. Peterson. Maarten Simoons. Galen
S. Wagner, Lynn H. Woodlief. Kerry L. Lee. Robert M. Califf. Christopher B. Granger.
GUSTO Investigators. Duke University Medical Center. Durham. North Carolina
Risk assessment for patients with acute myocardial infarction is critical in
facilitating appropriate therapeutic decision making and resource utilization.
Prior investigation of the GUSTO I database has identified 16 baseline clinical
variables that independently and accurately predict 3D-day mortality. We in-
vestigated the ability of the presenting electrocardiogram (ECG) to increase
the predictive capacity of the clinical data, with a particular focus on the
significance of ST segment shifts. We examined a 32,812 patient subset of
the 41 ,021 pt enrolled in GUSTO I. Exclusionary criteria included absence of
baseline ECG. LBBB, unknown 30-day mortality, <0.1 mV maximum ST ele-
vation, paced or ventricular rhythm. 30-day follow-up was greater than 99.5%
complete. Candidate ECG variables included LVH, RVH, ABBB. left anterior
and left posterior hemiblock (LAHB, LPHB), prior MI in a distinct anatomic
location, maximum ST elevation in anyone lead, sum of ST elevation in all
leads, number of leads with :0:0.1 mV ST elevation (NUMLEAD), sum of the
absolute ST deviation from baseline in all leads (SUMDEV). Multivariable lo-
gistic regression modelling of the ECG data alone showed SUMDEV, Prior
MI, NUMLEAD, ABBB and LAHB to provide independent prognostic infor-
mation. Stepwise addition of the ECG variables to the clinical data indicated
independent prognostic information in SUMDEV and ABBB (x 2 = 184). The
predictive value of this information was of similar magnitude to heart rate
and MI location and was an order of magnitude larger than that for time to
treatment, diabetes mellitus or smoking.
Multivariable Stepwise ECG Model
ECG Variable Adjusted X 2*
SUMDEV 229
Prior MI 89
NUMLEAD 54
RBBB 50
LAHB 16
Incremental Prognostic Value of
Electrocardiographic Findings when Added to
Baseline Clinical Variables in Patients with
Acute Myocardial Infarction
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In the GUSTO Angiographic Trial 1,175 patients underwent angiography at
a mean of 97 ± 12 min following thrombolysis with either t-PA, Streptoki-
nase, or a combination of both agents. For all treatment groups combined,
313 (27%) patients had TIMI 2 flow (T2). Of the patients with early TIMI 2
flow 151 (48%) continued to have TIMI 2 flow af follow-up (flu) angiography
a mean of 5.9 ± 1.9 days later. while in 162 (52%) the flow had improved to
TIMI 3. The plot on the left shows the minimum luminal diameter (MLD) for
patients with TIMI 2 flow at 90 minutes and 5-7 day flu vs those with TIMI
The Angiographic Fate of Infarct Related
Arteries with TIMI 2 Flow Following
Thrombolysis for Acute Myocardial Infarction
Jonathan S. Reiner, Conor F. Lundergan. Anthony Fung. Shyuan Cho. Noah Israel,
John Kazmierski. George Pilcher, James Smith. Steven Rohrbeck,
Mark Thom pson. Allan M. Ross. GUSTO Investigators. The George Washington
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Infarct expansion after acute anterior infarct has been described in both an-
imals and humans. Specific factors governing its development are not well
defined. No previous prospective studies have serially examined the effect
of underlying hypertrophy on infarct expansion in humans. Accordingly 2-D
echocardiograms from 47 patients (pts) after a first transmural anterior M.1.
were prospectively studied. A previously described expansion index (E.I.)
(E. I. = Endocardial length of infarct containing segmentlEndocardial length
of noninfarcted segment) and the ratio of infarct thickness to noninfarcted
thickness (liN) along with LV end diastolic volume index (LVEDVI), LV end sys-
tolic volume index (LVESVI), LV ejection fraction (LVEF). basal interventricular
septum (IVS) and posterior wall (PW) thickness were measured within 3 days
from admission at 1 week and at 3 months.
Pts were divided according to their baseline LV thickness into group I and
group II (IVS + PW = 24 ± 1 mm and 20 ± 2 mm (m ± SD) respectively). 20
pts formed group I and 27 group II. Medications in group I and groups II did
not differ in regard to beta blockers, Ace inhibitors, nitrates and thrombolysis.
Results:
Conclusions: Electrocardiographic variables add important information to
baseline clinical and demographic data capable of improving early risk strat-
ification of thrombolytic treated patients with acute myocardial infarction.
Appropriate use of this information should improve clinical decision making
and resource utilization.
Effect of Left Ventricular Hypertrophy on Infarct
Expansion
Michele Nanna. Jiajia Wu, Myung-Ho Lee. Antonio Palma, Mark Goldberger.
Montefiore Medical Center, Albert Einstein College of Medicine. Bronx. NY
